Moritsugu Kimura

579 total citations
48 papers, 358 citations indexed

About

Moritsugu Kimura is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery. According to data from OpenAlex, Moritsugu Kimura has authored 48 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Nephrology and 6 papers in Surgery. Recurrent topics in Moritsugu Kimura's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (12 papers) and Renal Diseases and Glomerulopathies (8 papers). Moritsugu Kimura is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (12 papers) and Renal Diseases and Glomerulopathies (8 papers). Moritsugu Kimura collaborates with scholars based in Japan, Brazil and United States. Moritsugu Kimura's co-authors include Masao Toyoda, Masaaki Miyauchi, Tomoya Umezono, Naoyuki Yamamoto, Masafumi Fukagawa, Takako Kobayashi, Makiko Abe, Mayuko Kato, Daisuke Suzuki and Keiko Kobayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Moritsugu Kimura

43 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moritsugu Kimura Japan 11 120 116 80 59 46 48 358
Mikio Sugano Japan 9 86 0.7× 40 0.3× 41 0.5× 75 1.3× 26 0.6× 28 313
Hüseyin Beğenik Türkiye 11 49 0.4× 50 0.4× 99 1.2× 63 1.1× 16 0.3× 30 374
Natsuko Suzuki Japan 12 75 0.6× 48 0.4× 49 0.6× 93 1.6× 20 0.4× 31 301
Takeshi Tana Japan 11 82 0.7× 39 0.3× 119 1.5× 44 0.7× 9 0.2× 26 415
Ron T. Gansevoort Netherlands 6 80 0.7× 32 0.3× 45 0.6× 16 0.3× 17 0.4× 17 233
Elise Lombard France 7 50 0.4× 50 0.4× 71 0.9× 62 1.1× 11 0.2× 9 378
Magdalena P. Cardelo Spain 12 24 0.2× 55 0.5× 97 1.2× 37 0.6× 61 1.3× 23 371
Nilay Dey United States 7 149 1.2× 14 0.1× 104 1.3× 52 0.9× 18 0.4× 7 357
Paul A. Davis United States 11 24 0.2× 49 0.4× 129 1.6× 32 0.5× 23 0.5× 16 349
Rachel Njeim Lebanon 9 31 0.3× 49 0.4× 69 0.9× 32 0.5× 10 0.2× 19 261

Countries citing papers authored by Moritsugu Kimura

Since Specialization
Citations

This map shows the geographic impact of Moritsugu Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritsugu Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritsugu Kimura more than expected).

Fields of papers citing papers by Moritsugu Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritsugu Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritsugu Kimura. The network helps show where Moritsugu Kimura may publish in the future.

Co-authorship network of co-authors of Moritsugu Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Moritsugu Kimura. A scholar is included among the top collaborators of Moritsugu Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritsugu Kimura. Moritsugu Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Kazuo, Kei Takeshita, Takuya Hashimoto, et al.. (2025). Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study). Journal of Diabetes Investigation. 16(7). 1243–1253. 1 indexed citations
2.
Sawada, Kaichiro, Y Matsuda, Makiko Abe, et al.. (2024). Study of the Effects of Deuterium-Depleted Water on the Expression of GLUT4 and Insulin Resistance in the Muscle Cell Line C2C12. Biomedicines. 12(8). 1771–1771. 1 indexed citations
3.
Toyoda, Masao, et al.. (2023). Regulation of Renin Expression by Β1-Integrin in As4.1 Juxtaglomerular Line Cells. Biomedicines. 11(2). 501–501.
4.
Koizumi, Masahiro, Genta Kanai, Hirotaka Komaba, et al.. (2023). Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients. Scientific Reports. 13(1). 93–93. 15 indexed citations
5.
6.
Kimura, Moritsugu, et al.. (2022). Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports. Renal Replacement Therapy. 8(1). 14–14. 3 indexed citations
7.
Toyoda, Masao, et al.. (2021). Regulation of Blood Pressure and Phosphorylation of β1-integrin in Renal Tissue in a Rat Model of Diabetic Nephropathy.. PubMed. 46(4). 172–179. 2 indexed citations
8.
Yamada, Chizumi, Noriaki Kishimoto, Moritsugu Kimura, et al.. (2020). Relationship between Serum Antioxidative Vitamin Concentrations and Type 2 Diabetes in Japanese Subjects. Journal of Nutritional Science and Vitaminology. 66(4). 289–295. 6 indexed citations
9.
Sakane, Naoki, Takashi Murata, Atsuhito Tone, et al.. (2019). Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale. Diabetes Technology & Therapeutics. 22(3). 216–221. 8 indexed citations
10.
Murata, Takashi, Atsuhito Tone, Ryuji Kouyama, et al.. (2019). The Effect of High-concentration Insulin Glarigine on the Quality of Life of Patients with Type 2 Diabetes Mellitus: A Pre-post Study (HIGH-QOL STUDY). Internal Medicine. 58(20). 2943–2948. 1 indexed citations
11.
12.
Toyoda, Masao, et al.. (2017). Favorable Effect on Blood Volume Control in Hemodialysis Patients with Type 2 Diabetes after Switching from Insulin Therapy to Liraglutide, a Human Glucagon-like Peptide-1 Analog--Results from a Pilot Study in Japan-.. PubMed. 42(1). 52–57. 6 indexed citations
13.
Yanagi, Hidetaka, Masahiro Koizumi, Moritsugu Kimura, et al.. (2012). Pasteurella multocida peritonitis associated with a cat in a peritoneal dialysis patient using an automated cycler device. CEN Case Reports. 1(2). 73–76. 7 indexed citations
14.
Toyoda, Masao, Moritsugu Kimura, Naoyuki Yamamoto, et al.. (2012). Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis. Journal of Nephrology. 25(6). 989–995. 11 indexed citations
15.
Suzuki, Daisuke, Masao Toyoda, Eitaro Tanaka, et al.. (2012). Efficacy of long-acting insulin analog insulin glargine at high dosage for basal-bolus insulin therapy in patients with type 2 diabetes.. PubMed. 37(2). 35–40. 10 indexed citations
16.
Yamamoto, Naoyuki, Masao Toyoda, Makiko Abe, et al.. (2009). Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Expression in the Tubulointerstitial Area Likely Plays an Important Role in Human Diabetic Nephropathy. Internal Medicine. 48(4). 189–194. 25 indexed citations
17.
Toyoda, Masao, Tomoya Umezono, Makiko Abe, et al.. (2008). Intensive insulin therapy for Japanese patients with type 2 diabetes mellitus--results in the patients from single hospital.. PubMed. 33(2). 95–9. 2 indexed citations
18.
Kimura, Moritsugu, et al.. (2007). [Quality of Life Instrument for Youths with Diabetes].. PubMed. 28(4). 512–9. 3 indexed citations
19.
Toyoda, Masao, Tomoya Umezono, Masaaki Miyauchi, et al.. (2006). [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].. PubMed. 48(1). 14–21. 1 indexed citations
20.
Kobayashi, Kensuke, et al.. (1992). Influence of Blood Proteins on Biomedical Analysis. XII. Effects of Glycation on Gliclazide (Oral Hypoglycemic Drug)-Binding with Serum Albumin in Diabetics.. Chemical and Pharmaceutical Bulletin. 40(1). 255–257. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikio Sugano Breakdown of academic impact, for papers by Hüseyin Beğenik Breakdown of academic impact, for papers by Natsuko Suzuki Breakdown of academic impact, for papers by Takeshi Tana Breakdown of academic impact, for papers by Ron T. Gansevoort Breakdown of academic impact, for papers by Elise Lombard Breakdown of academic impact, for papers by Magdalena P. Cardelo Breakdown of academic impact, for papers by Nilay Dey Breakdown of academic impact, for papers by Paul A. Davis Breakdown of academic impact, for papers by Rachel Njeim
Rankless by CCL
2026